Edwards Lifesciences Launches ‘Stay in the Race’ Urging Early Action Against Treatable Heart Valve Failure

Partnership with Rahal Letterman Lanigan Racing to raise awareness of heart valve failure among adults 65+

IRVINE, Calif. - Edwards Lifesciences today introduced "Stay in the Race," a national disease awareness effort that highlights the urgency of recognizing heart valve failure (severe aortic stenosis) before symptoms become life-threatening.

The initiative, created in partnership with Rahal Letterman Lanigan (RLL) Racing, taps into auto racing as a metaphor for heart valve health, emphasizing the importance of early detection and timely referral among adults 65 and older.

RLL co-owners Bobby Rahal, David Letterman and Mike Lanigan have each faced significant heart health challenges. Notably, Lanigan was diagnosed with heart valve failure and, following evaluation by his heart valve team, was treated with Transcatheter Aortic Valve Replacement (TAVR). Their personal heart health experiences bring urgency and credibility to a simple but critical message: Don't wait; get your heart valves checked.

"Heart valve failure is often silent until it's too late, but it's treatable - and a simple screening can save a life," said Dan Lippis, corporate vice president of TAVR at Edwards. "This initiative is about empowering people with the knowledge they need to take charge of their heart health. Early detection and timely treatment can turn a preventable tragedy into a second chance at life."

Through this partnership, Edwards and RLL will use high-visibility moments throughout the year, including the Acura Grand Prix of Long Beach and the Indianapolis 500, to elevate public understanding of heart valve failure. As part of these efforts, the initiative will be anchored by a documentary short film focused on the real-life heart health journeys of Rahal, Letterman and Lanigan.

While the disease can affect anyone, adults 65 and older and people with certain health conditions face higher risk. For many, a heart murmur detected during a routine stethoscope exam may be the first - and sometimes only - warning sign. Like a critical pit stop supports the mechanical health of race cars, this early check helps identify people sooner and supports prompt referral to a specialized heart valve team for evaluation.

"Partnering with Edwards Lifesciences allows us to raise awareness of treatable heart valve failure and encourage individuals - especially older adults - to prioritize and ask about their heart health," said Rahal, a three-time INDYCAR Champion and 1986 Indianapolis 500 winner. "By sharing our own experiences, we hope to spark conversations that lead to earlier detection and better outcomes."

Watch the new trailer at www.GetYourValvesChecked.com to learn more about "Stay in the Race" and heart valve failure.
About Edwards Lifesciences

Edwards Lifesciences is the leading global structural heart innovation company, driven by a passion to improve patient lives. Through breakthrough technologies, world-class evidence and partnerships with clinicians and healthcare stakeholders, our employees are inspired by our patient-focused culture to deliver life-changing innovations to those who need them most. Discover more at www.edwards.com and follow us on LinkedIn, Facebook, Instagram and YouTube.

This news release includes forward-looking statements within the meaning of Section 27A of the Securities Act of 1933, as amended, and Section 21E of the Securities Exchange Act of 1934, as amended. These forward-looking statements include, but are not limited to, statements made by Mr. Lippis and statements regarding expected product benefits and outcomes and other statements that are not historical facts. Forward-looking statements are based on estimates and assumptions made by management of the company and are believed to be reasonable, though they are inherently uncertain and difficult to predict. Our forward-looking statements speak only as of the date on which they are made, and we do not undertake any obligation to update any forward-looking statement to reflect events or circumstances after the date of the statement. Investors are cautioned not to unduly rely on such forward-looking statements.

Forward-looking statements involve risks and uncertainties that could cause results to differ materially from those expressed or implied by the forward-looking statements based on a number of factors as detailed in the company's filings with the Securities and Exchange Commission. These filings, along with important safety information about our products, may be found at Edwards.com.

Edwards, Edwards Lifesciences, the stylized E logo, are trademarks of Edwards Lifesciences Corporation. All other trademarks are the property of their respective owners.

# # #